061250 — Hwail Pharm Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapNeutral

Annual cashflow statement for Hwail Pharm Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	2,842	-6,327	3,863	6,481	-233
Depreciation
Amortisation
Non-Cash Items	348	8,008	2,852	2,579	-1,329
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	14,814	-3,789	-853	1,302	11,983
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	20,088	-234	7,025	11,634	11,878
Capital Expenditures	-2,471	-10,392	-2,102	-34,634	-3,995
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-34,314	20,228	21,837	-14,929	-348
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities	-36,785	9,836	19,735	-49,563	-4,343
Financing Cash Flow Items	-132	-10.2	0	-51.2	-13.6
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	21,130	-4,043	-5,101	24,907	-158
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	4,778	5,927	21,777	-12,719	7,363